K-numberK241009
Device namePeriCALM Patterns 3.0
ApplicantPerigen, Inc.
Product codeHGM
Device classClass II
Decision dateJan 10, 2025
DecisionSubstantially Equivalent
Regulation884.2740
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

PeriCALM Patterns 3.0 is a software device that analyzes electronic fetal heart rate and uterine contraction recordings to automatically detect and label fetal heart rate patterns (accelerations, decelerations, baseline) and contractions. It is intended as an adjunct to clinical decision-making during antepartum or intrapartum obstetrical monitoring at ≥32 weeks gestation, providing secondary information to support but not replace direct clinician evaluation.

Technological characteristics

The subject device uses Long and Short-Term Memory (LSTM) neural networks for pattern recognition, whereas the predicate uses signal processing and neural networks. Key differences include: neural network interference for combined accel-decel-baseline plus non-interpretable segment detection (new feature); analysis time intervals of 15 or 30 minutes versus 20 minutes; and handling of missing tracing segments (new capability). Contraction detection uses the same processes as the predicate.

Test standards cited

Not stated in this summary. The document references FDA 2023 guidance documents on device software and cybersecurity but does not cite specific ISO, IEC, or ASTM consensus standards.

Substantial equivalence argument

The device is substantially equivalent because: (1) intended use is identical—both serve as adjuncts to clinical decision-making during obstetrical monitoring; (2) the lower gestational age threshold (≥32 weeks vs. ≥36 weeks) does not raise different safety or effectiveness questions; (3) technological differences (neural network interference, modified time intervals, non-interpretable segment handling) do not raise different safety or effectiveness questions; and (4) clinical performance testing demonstrated non-inferiority to both ground truth expert consensus and clinician readers across both preterm and term gestational age groups on all 16 co-primary endpoints.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →